Clinical trials
Hyperparathyroidism, Secondary trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo General Hospital | 2 |
| Azienda Ospedaliera Sant'Anna | 1 |
| Denver Nephrologists, P.C. | 1 |
| Hospital Regional 1o de Octubre | 1 |
| Kumamoto University | 1 |
| Mayo Clinic | 1 |
| McMaster University | 1 |
| Penang Hospital, Malaysia | 1 |
| Phramongkutklao College of Medicine and Hospital | 1 |
| Roxane Laboratories | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 19 |
| Renal Insufficiency, Chronic | 8 |
| Hyperparathyroidism | 5 |
| Kidney Failure, Chronic | 4 |
| Vitamin D Deficiency | 3 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 2 |
| Vascular Calcification | 2 |
| Anemia | 1 |
| Bone Diseases, Metabolic | 1 |
| Hyperparathyroidism, Primary | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.